ByHeart Formula Linked to Botulism Cases Months Before Official Outbreak

At least 31 infants across 15 states hospitalized with botulism; additional cases in California treated for the rare, potentially deadly disease requiring IV medication (BabyBIG) for recovery.
This cannot be a coincidence
A mother's realization when she learned ByHeart formula was linked to her son's botulism diagnosis months after his illness.
Mark

So we have six confirmed cases in California going back to November 2024, but the official outbreak investigation didn't start until August. Why the gap?

Mimi

At the time, there wasn't enough evidence to point to a common source. Botulism in babies is rare but not unheard of—usually it comes from environmental spores or honey. The cases seemed scattered, within normal range. No one suspected formula.

Luke

But ByHeart formula tested positive for the bacteria. So why couldn't they connect it then?

Mimi

The test of an open can from spring didn't detect it. And ByHeart accounts for less than one percent of infant formula sold in the U.S. The signal only became clear when cases clustered in August and October on the East Coast, involving a toxin type rarely seen there, hitting very young infants.

Mark

So it's a numbers game. You need enough cases in one place at one time to see the pattern.

Mimi

Exactly. Before August, the numbers looked normal. After August, they didn't.

Luke

But the CDC says they're aware of the earlier cases. They're just focusing on the surge. That feels like a choice to narrow the investigation.

Mimi

Dr. Cope says it's not that they're excluding them—it's just where the resources are going. But she also admits time and missing lot numbers make it harder to prove the link now.

Mark

The parents are frustrated because they've been living with this for months without answers.

Mimi

Right. Connolly asked directly: why did August cases trigger an investigation but March cases didn't? She wants to know the data that explains how her baby got sick.

Luke

Food safety experts say earlier cases should be counted as part of the outbreak if babies consumed ByHeart and got botulism. The CDC's focus on the surge might be missing the fuller picture.

  • Infants across multiple states were hospitalized with a rare, potentially deadly illness before any official alarm was raised, leaving families to search alone for answers that health systems had not yet assembled.
  • ByHeart formula tested positive for botulism-causing bacteria only after a nationwide recall in November 2025, but earlier open-can tests had returned negative results, obscuring the trail for investigators.
  • Health officials argue the pre-August cases fell within statistically normal ranges and lacked a visible common source — a defensible position that parents and food safety experts find deeply inadequate.
  • Food safety lawyer Bill Marler and former FDA deputy commissioner Frank Yiannas are pressing for earlier cases to be formally included in the outbreak investigation, arguing the evidentiary bar is being applied inconsistently.
  • Missing lot numbers and discarded formula cans now make it nearly impossible for early-affected families to prove their connection to the outbreak, compounding their grief with bureaucratic invisibility.

Long before regulators recognized an outbreak, infants were falling ill in ways their parents could not yet name. The story of ByHeart formula and infant botulism is, at its core, a story about the gap between pattern and proof — about how institutions require a critical mass of suffering before a signal becomes a crisis. At least six California babies were treated for botulism as early as November 2024, months before the August surge that triggered a nationwide recall, raising a question that haunts every public health failure: when does a coincidence become a warning, and who bears the cost of the delay?

In March, Amy Mazziotti's five-month-old son Hank became ill after drinking ByHeart formula. Weeks passed without a diagnosis. It was only in November — when ByHeart recalled all its products following a surge of infant botulism cases — that the cause snapped into focus for her. But Hank had been sick eight months before the outbreak was officially recognized.

California health officials confirmed that six babies in the state were treated for botulism after consuming ByHeart formula between November 2024 and June 2025. Katie Connolly's daughter was among them, hospitalized in April. At the time, neither mother knew what had made their children sick. Infant botulism typically traces to environmental spores or contaminated honey — not formula. The connection was invisible.

When laboratory tests of unopened ByHeart formula eventually revealed the botulism-causing bacterium, the company confirmed the finding. Food safety lawyer Bill Marler says at least three additional pre-August cases involved babies who consumed ByHeart and were treated for botulism. Yet officials say they cannot definitively connect these earlier illnesses to the current outbreak of 31 or more infants across 15 states.

Officials explain that before August, case numbers fell within expected ranges, no powdered infant formula in the U.S. had ever tested positive for botulism bacteria, and a test of an open formula can fed to a sick baby returned negative. The pattern only became visible when cases clustered on the East Coast in August and October, involving a toxin type rarely seen there and disproportionately affecting very young infants.

CDC scientist Dr. Jennifer Cope acknowledges awareness of earlier reports but says the investigation remains focused on the documented surge since August 1, noting that time and missing documentation make earlier links harder to establish. Connolly finds this unconvincing. Former FDA deputy commissioner Frank Yiannas and food safety advocates argue the earlier cases should be counted as part of the outbreak without question. For the families who lived through those early months without answers, the investigation's narrow focus feels like a second erasure.

In March, Amy Mazziotti's five-month-old son Hank fell ill after drinking ByHeart formula. Weeks of uncertainty followed—no clear diagnosis, no obvious cause. Then in November, ByHeart recalled all its products nationwide after health officials linked the brand to a surge of infant botulism cases. The moment Mazziotti heard the news, the pieces clicked into place. "This cannot be a coincidence," she thought.

But there was a problem with that clarity: Hank's illness had occurred eight months before the outbreak was officially recognized. He was not alone. California public health officials confirmed late last week that six babies in the state had been treated for botulism after consuming ByHeart formula between November 2024 and June 2025—months before the current outbreak sickened at least 31 infants across 15 states. Katie Connolly's eight-month-old daughter, M.C., was hospitalized in April after being fed ByHeart formula. At the time, neither mother knew what had made their children sick. Botulism in infants typically traces back to environmental spores or contaminated honey, not formula. The connection seemed invisible.

When ByHeart recalled its products on November 11, laboratory tests of unopened formula revealed the answer: some samples contained the bacterium responsible for infant botulism. The company's confirmation came this week. Food safety lawyer Bill Marler, representing affected families, says at least three additional cases predating the August outbreak involved babies who consumed ByHeart and were treated for botulism—one in December 2024, two more in spring. Yet health officials maintain they cannot definitively connect these earlier illnesses to the current outbreak.

The reasoning is straightforward but unsatisfying to parents. California health officials stated there was "not enough evidence to immediately suspect a common source" when those six cases appeared. Before this outbreak, no powdered infant formula in the U.S. had tested positive for botulism-causing bacteria. The number of cases fell within expected ranges. A test of an open can of formula fed to a sick baby in spring did not detect the bacterium. Only when cases began clustering in August and October—concentrated on the East Coast, involving a toxin type rarely seen in that region, and disproportionately affecting very young infants—did the pattern become visible. The signal only strengthened when a sample from a can of ByHeart formula fed to a sick infant tested positive.

Dr. Jennifer Cope, the CDC scientist leading the investigation, acknowledges the agency is aware of reports of earlier illnesses. But federal efforts remain focused on the documented surge since August 1. "That doesn't mean that they're not necessarily part of this," Cope said. "It's just that right now, we're focusing on this large increase." She added that time and missing documentation make it harder to definitively link earlier cases. Parents who did not record lot numbers or retain empty formula cans cannot easily prove the connection now.

Connolly finds this reasoning hollow. "What I want to know is why did the cases beginning in August flag an investigation, but the cases that began in March did not?" she asked. Outside experts agree. Frank Yiannas, former deputy commissioner for food policy at the FDA, said earlier cases should absolutely be counted as part of the outbreak if babies consumed ByHeart and were treated for botulism. "Why wouldn't they be included?" he asked. Sandra Eskin, chief executive of STOP Foodborne Illness, framed the stakes plainly: "This outbreak is traumatic for parents. They may have fed their newborns and infants a product they assumed was safe. And now they're dealing with hospitalization and serious illness of their babies."

Botulism causes constipation, poor feeding, weakness in the head and limbs, and other complications. Both Mazziotti and Connolly say their children are improving, though lingering effects remain. After months of searching for answers, Connolly became what she describes as "completely obsessed" with linking ByHeart to her daughter's illness. Now she wants the data that explains how her baby got sick. The question hanging over this outbreak is whether the investigation's focus on the recent surge has left earlier cases—and the families who lived through them—in shadow.

What I want to know is why did the cases beginning in August flag an investigation, but the cases that began in March did not?
— Katie Connolly, mother of an infant treated for botulism in April
Absolutely, yes, they should be included. Why wouldn't they be included?
— Frank Yiannas, former FDA deputy commissioner for food policy, on whether pre-August cases should count as part of the outbreak
Envie de l'histoire complète ? Lire l'original sur WTOP ↗
Nous contacter FAQ